Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-26T20:22:32.488Z Has data issue: false hasContentIssue false

“I have brain fog…” About cognitive impairment after COVID-19

Published online by Cambridge University Press:  01 September 2022

H. Ghabi
Affiliation:
Razi Hospital, Department Of Psychiatry A, manouba, Tunisia
A. Aissa*
Affiliation:
Razi Hospital, Department Of Psychiatry A, Manouba, Tunisia
A. Zili
Affiliation:
Razi Hospital, Department Of Psychiatry A, Manouba, Tunisia
A. Ben Cheikh Ahmed
Affiliation:
Razi Hospital, Department Of Psychiatry A, manouba, Tunisia
Y. Zgueb
Affiliation:
Razi Hospital, Department Of Psychiatry A, manouba, Tunisia
S. Madouri
Affiliation:
Razi Hospital, Department Of Psychiatry A, manouba, Tunisia
U. Ouali
Affiliation:
Razi Hospital, Department Of Psychiatry A, manouba, Tunisia
R. Jomli
Affiliation:
Razi Hospital, Department Of Psychiatry A, manouba, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Much has been learned about SARS-CoV-2. However, the mechanism of short or long-term neuropsychiatric symptoms remains unclear. several hypotheses, including lack of oxygen caused by lung damage, inflammation affecting brain cells, or Lack of blood flow caused by swelling of the small blood vessels in the brain, have been advanced to explain these symptoms.

Objectives

Herein, we presented a case of cognitive impairment diagnosed after infection with COVID 19.

Methods

We discussed, through a clinical case, the possible mechanisms and risk factors of cognitive impairment following COVID 19 infection.

Results

This case concerned a 28 –year-old patient. He had no personal or family psychiatric. In August 2021, he presented a SARS-CoV-2 infection without hypoxemia or respiratory failure. On day 10 the patient recovered. Two days after, he consulted our psychiatric department as he experienced impairment in memory. He had impairment in attention and executive function, and in particular verbal fluency. He said that his thinking was sluggish, fuzzy, and not sharp. He denied any alcohol or drug abuse. He was euthymic and he had no depressive symptoms. Arterial blood gas, laboratory, and clinical findings were normal. A brain CT scan with contrast was performed and did not show any abnormality.

Conclusions

This case highlighted the possible cognitive consequences of COVID-19 during the recovery phase. Further work is required to identify risk factors of psychiatric symptoms following COVID-19 infection and their management.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.